No title
Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with regard to its clinical course. The limitations of the methods currently available for prognostic assessment in CLL do not allow accurate prediction of the risk of disease progression in Individual patients. The recently developed cDNA array technique provides a unique opportunity to study gene expression in various malignancies. To
